Published in PLoS One on November 12, 2013
Cutaneous Mechanoreceptor Feedback from the Hand and Foot Can Modulate Muscle Sympathetic Nerve Activity. Front Neurosci (2016) 0.75
Increased mechanoreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol (1985) (2006) 7.74
Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol (1985) (2007) 4.02
Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J (2000) 2.70
The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol (2003) 2.52
Beneficial effects of chronic low-frequency stimulation of thigh muscles in patients with advanced chronic heart failure. Eur Heart J (2004) 1.87
Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol (1996) 1.76
Comparison of low-frequency electrical myostimulation and conventional aerobic exercise training in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil (2005) 1.71
Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol (2008) 1.47
Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure. Circulation (1991) 1.33
The reliability of short-term measurements of heart rate variability. Int J Cardiol (2005) 1.30
Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur J Heart Fail (2007) 1.20
Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol (2009) 1.18
Decreased activity of spontaneous and noxiously evoked dorsal horn cells during transcutaneous electrical nerve stimulation (TENS). Pain (1994) 1.14
Sympathetic reflex control of blood flow in human peripheral tissues. Acta Physiol Scand Suppl (1991) 1.05
Training-induced adaptations in the central command and peripheral reflex components of the pressor response to isometric exercise of the human triceps surae. J Physiol (1999) 1.05
Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies. Auton Neurosci (2008) 1.01
Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation (1984) 0.99
Functional electrical stimulation improves endothelial function and reduces peripheral immune responses in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil (2006) 0.99
Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev (2000) 0.97
Functional electrical stimulation in the treatment of patients with chronic heart failure: a meta-analysis of randomized controlled trials. Eur J Cardiovasc Prev Rehabil (2010) 0.96
Skeletal muscle afferent fibres release substance P in the nucleus tractus solitarii of anaesthetized cats. J Physiol (1999) 0.96
Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers. Eur J Heart Fail (2008) 0.95
Inhibition of human muscle sympathetic activity by sensory stimulation. J Physiol (2002) 0.94
Low-frequency electrical stimulation increases muscle strength and improves blood supply in patients with chronic heart failure. Circ J (2006) 0.93
Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (2002) 0.93
Functional electrical stimulation for chronic heart failure: a meta-analysis. Int J Cardiol (2012) 0.92
Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients. J Card Fail (2004) 0.92
Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci (Lond) (1997) 0.91
Spinal nociceptin mediates electroacupuncture-related modulation of visceral sympathoexcitatory reflex responses in rats. Am J Physiol Heart Circ Physiol (2009) 0.89
Transcutaneous electrical nerve stimulation for the control of pain in musculoskeletal disorders. J Orthop Sports Phys Ther (1996) 0.87
Modulation of cardiovascular excitatory responses in rats by transcutaneous magnetic stimulation: role of the spinal cord. J Appl Physiol (1985) (2005) 0.86
Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J Hypertens (2009) 0.85
Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia. Hypertension (2010) 0.83
Chemoreflex and metaboreflex control during static hypoxic exercise. Am J Physiol Heart Circ Physiol (2004) 0.83
Effects of transcutaneous electrical nerve stimulation (TENS) on spontaneous and noxiously evoked dorsal horn cell activity in cats with transected spinal cords. Neurosci Lett (1996) 0.82
Electrical muscle stimulation for chronic heart failure: an alternative tool for exercise training? Curr Heart Fail Rep (2010) 0.82
Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity. Int J Cardiol (2013) 0.81
Peripheral nerve stimulation suppression of C-fiber-evoked flexion reflex in rats. Part 2: Parameters of low-rate train stimulation of skin and muscle afferent nerves. J Neurosurg (1988) 0.81
Rehabilitation: Periodic somatosensory stimulation increases arterial baroreflex sensitivity in chronic heart failure patients. Int J Cardiol (2010) 0.79
Low-frequency electromyostimulation and chronic heart failure. Ann Readapt Med Phys (2008) 0.79
Sympathetic nerve activity after thoracoscopic cardiac resynchronization therapy in congestive heart failure. J Card Fail (2005) 0.77
Effects of substance P on cardiovascular regulation in the rabbit. J Auton Nerv Syst (1995) 0.76
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol (2011) 5.60
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol (2007) 3.09
New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance. Mov Disord (2004) 2.76
Comparison of gas exchange data using the Aquatrainer system and the facemask with Cosmed K4b2 during exercise in healthy subjects. Eur J Appl Physiol (2010) 2.73
Adrenomedullin inhibits adipogenesis under transcriptional control of insulin. Diabetes (2007) 2.03
Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Headache (2003) 1.97
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol (2013) 1.69
The phase of ongoing oscillations mediates the causal relation between brain excitation and visual perception. J Neurosci (2011) 1.63
Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol (2007) 1.60
B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J (2009) 1.56
Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol (2013) 1.55
Correlation between cerebral reorganization and motor recovery after subcortical infarcts. Neuroimage (2003) 1.51
Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol (2006) 1.50
Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment. BJU Int (2010) 1.47
Risk of neurological decompression sickness in the diver with a right-to-left shunt: literature review and meta-analysis. Clin J Sport Med (2009) 1.46
Deciphering biased-agonism complexity reveals a new active AT1 receptor entity. Nat Chem Biol (2012) 1.44
Sympathoexcitation increases the QT/RR slope in healthy men: differential effects of hypoxia, dobutamine, and phenylephrine. J Cardiovasc Electrophysiol (2007) 1.43
Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23
Giant cell arteritis as a cause of acute myocarditis in the elderly. J Rheumatol (2011) 1.20
Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. JAMA (2011) 1.19
Prognostic value of FMRI in recovery of hand function in subcortical stroke patients. Cereb Cortex (2007) 1.12
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme. Eur J Heart Fail (2009) 1.11
Low-temperature plasmas at atmospheric pressure: toward new pharmaceutical treatments in medicine. Fundam Clin Pharmacol (2013) 1.08
Reversal of dilated cardiomyopathy by the elimination of frequent left or right premature ventricular contractions. J Interv Card Electrophysiol (2007) 1.06
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail (2012) 1.04
Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol (2010) 1.04
ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. J Biol Chem (2006) 1.04
Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett (2010) 1.03
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. Eur Heart J (2012) 1.02
Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens (2012) 1.00
Mediastinal lymphadenopathy in congestive heart failure: a sequential CT evaluation with clinical and echocardiographic correlations. Eur Radiol (2003) 0.99
Relationship between time of day, day of the week and in-hospital mortality in patients undergoing emergency percutaneous coronary intervention. Arch Cardiovasc Dis (2009) 0.98
Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study. Neurourol Urodyn (2011) 0.98
Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension (2006) 0.96
Adiponectin and long-term mortality in coronary artery disease participants and controls. Arterioscler Thromb Vasc Biol (2012) 0.95
Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J Mol Cell Cardiol (2009) 0.94
Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. Br J Clin Pharmacol (2008) 0.93
Theta oscillations modulate attentional search performance periodically. J Cogn Neurosci (2014) 0.92
Anxiodepressive disorders and chronic psychological stress are associated with Tako-Tsubo cardiomyopathy- New Physiopathological Hypothesis. Circ J (2012) 0.92
Imidazolyl-PEI modified nanoparticles for enhanced gene delivery. Int J Pharm (2006) 0.91
High-intensity interval exercise in chronic heart failure: protocol optimization. J Card Fail (2011) 0.91
Cardiac transcriptome analysis in obesity-related hypertension. Hypertension (2003) 0.91
Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database. Fundam Clin Pharmacol (2013) 0.90
Chemoreflex and metaboreflex responses to static hypoxic exercise in aging humans. Med Sci Sports Exerc (2006) 0.90
Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension. Fundam Clin Pharmacol (2011) 0.90
Thrombolysis by recombinant tissue plasminogen activator during pregnancy: a case of massive pulmonary embolism. Am J Emerg Med (2010) 0.89
Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart. J Clin Invest (2014) 0.89
Blood signature of pre-heart failure: a microarrays study. PLoS One (2011) 0.88
Exposure to extreme cold lowers the ischemic threshold in coronary artery disease patients. Can J Cardiol (2010) 0.87
A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Biochem Biophys Res Commun (2007) 0.87
Increase in group II excitation from ankle muscles to thigh motoneurones during human standing. J Physiol (2005) 0.87
Relationship between left ventricular sphericity and trabeculation indexes in patients with dilated cardiomyopathy: a cardiac magnetic resonance study. Eur Heart J Cardiovasc Imaging (2013) 0.86
Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol (2012) 0.86
Methylphenidate modulates cerebral post-stroke reorganization. Neuroimage (2006) 0.86
Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction. Neurourol Urodyn (2011) 0.86
Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol (2013) 0.86
Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. Eur J Clin Pharmacol (2012) 0.86
[Sleep apnea syndromes and cardiovascular disease]. Bull Acad Natl Med (2005) 0.86
Induction of cortical plastic changes in wrist muscles by paired associative stimulation in the recovery phase of stroke patients. Neurorehabil Neural Repair (2008) 0.86
Is exercise testing useful to improve the prediction of coronary events in asymptomatic subjects? Eur J Cardiovasc Prev Rehabil (2006) 0.86
Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J Hypertens (2009) 0.85
Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure. Clin Res Cardiol (2012) 0.85
High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure. Med Sci Sports Exerc (2013) 0.85
Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure. NDT Plus (2008) 0.85
High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. Am J Cardiovasc Drugs (2010) 0.85
New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value. Cardiovasc Diabetol (2013) 0.85
Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database. Eur J Clin Pharmacol (2011) 0.85
QT dynamicity: a prognostic factor for sudden cardiac death in chronic heart failure. Eur J Heart Fail (2005) 0.84
Prognostic usefulness of clinical and subclinical peripheral arterial disease in men with stable coronary heart disease. Am J Cardiol (2012) 0.84
Uncomplicated human obesity is associated with a specific cardiac transcriptome: involvement of the Wnt pathway. FASEB J (2004) 0.84
Induction of cortical plastic changes in wrist muscles by paired associative stimulation in healthy subjects and post-stroke patients. Exp Brain Res (2007) 0.84
Kinetic analysis of cardiac transcriptome regulation during chronic high-fat diet in dogs. Physiol Genomics (2004) 0.83
Telephone support oriented by accelerometric measurements enhances adherence to physical activity recommendations in noncompliant patients after a cardiac rehabilitation program. Arch Phys Med Rehabil (2012) 0.83
Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Pharmacoepidemiol Drug Saf (2011) 0.83
Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry. Rev Esp Cardiol (Engl Ed) (2012) 0.83
Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia. Hypertension (2010) 0.83
Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption. Fundam Clin Pharmacol (2009) 0.83
A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE. Eur J Paediatr Neurol (2011) 0.82
Bent spine syndrome: computed tomographic study and isokinetic evaluation. Muscle Nerve (2002) 0.82
A single bout of high-intensity interval exercise does not increase endothelial or platelet microparticles in stable, physically fit men with coronary heart disease. Can J Cardiol (2013) 0.82
The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated beta-adrenergic agonist oxidation. FASEB J (2005) 0.82
Dynamics of cerebral blood flow autoregulation in hypertensive patients. J Neurol Sci (2002) 0.81
Cross-linked polyethylenimine-hexametaphosphate nanoparticles to deliver nucleic acids therapeutics. Nanomedicine (2009) 0.81
Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity. Int J Cardiol (2013) 0.81